期刊文献+

不同配比的阿莫西林/舒巴坦钠体外抗菌活性比较 被引量:4

Comparison of in vitro antibacterial activities for different ratio of amoxicillin/sulbactam
下载PDF
导出
摘要 目的:研究阿莫西林(AMC)/舒巴坦(SBT)不同配比(2:1和4:1)对临床分离致病菌的体外抗菌活性。方法:采用平皿二倍稀释法测定最低抑苗浓度(MIC)。采集临床分离致病菌共620株,其中502株细菌为产β-内酰胺酶菌株(占80.97%)。结果:对产超广谱β-内酰胺酶(ESBL)大肠埃希菌和肺炎克雷伯菌、易产诱导酶的肠杆菌属及非发酵G-杆菌中铜绿假单胞菌、不动杆菌、嗜麦芽菌,AMC/SBT 4:1配比的MIC值为2:1配比时的1-2倍,但均属耐药范围。对社区感染常见菌如产酶的流感嗜血杆菌、卡他莫拉菌、甲氧西林敏感的金葡球菌(MSSA)及凝固酶阴性葡萄球菌(MSSCoN)、肺炎链球菌、β-溶血链球菌和粪肠球菌,2种配比的MIC值均相似。结论:AMC/SBT 4:1抗菌活性与2:1配比基本相同,具有进一步研制开发的价值。 Objective:To evaluate the antibacterial activities in vitro of amoxicillin/sulbactam (2:1 and 4:1). Methods:Minimal inhibitory concentrations (MIC) were determined by agar double dilution. Of 620 strains of clinical organisms, 502 cultures of organisms were found to be able to produce β-lactamases (80.97%). Results:Two combinations of amoxicillin/sulbactam (2:1 and 4:1) all showed resistant antibacterial activities with fluctuated MIC range,MIC50 and MIC90 in 1-2 times on the following organisms: Escherichia coli of ESBL, Klebsiella pneumoniae of ESBL, Enterobacter spp producing AmpC enzyme and non-fermentation gram negative rod ( Pseudomonas aeruginosa , Acineto-bacter spp, Stenophotomonas maltophilus). Two combinations of amoxicillin/sulbactam (2:1 and 4:1) also gave an equivalent titer in the MIC range,MIC50 and MIC90 on common pathogenic bacteria that cause community infection,i.e. ,Haemophilus Influenza producing β-lactamases,Moraxella catarrh , MSSA and MSSCoN, Streptococcus pneumoniae, β-haemolysis Streptococcus and Enterococcus fae-calis. Conclusion: Amoxicillin/sulbactam (4:1) was found to have the same antibacterial activity as amoxicillin/sulbactam (2:1).
出处 《中国新药杂志》 CAS CSCD 北大核心 2004年第11期1030-1033,共4页 Chinese Journal of New Drugs
关键词 阿莫西林/舒巴坦钠 体外抗菌活性 最低抑菌浓度 amoxicillin/sulbactam in vitro antibacterial activity MIC
  • 相关文献

参考文献5

  • 1[1]李继光.抗生素及化学药物治疗[M].第7版.沈阳:辽宁教育出版社,2000.277.
  • 2[2]Akalin HE.The role of Beta-lactam/beta-lactamase inhibitors in the management of mixed infections[J].Int J Antimicrob Agents,1999,12(Suppl 1.1):S15-S20.
  • 3刘又宁,王睿,王培兰,殷凯生,施毅,李梅梅,肖永营,刘佳,高建平,邹淑荣,葛京平.阿莫西林钠/舒巴坦钠治疗急性细菌性感染疾病的多中心临床研究[J].中国临床药理学杂志,2003,19(5):323-329. 被引量:6
  • 4[4]National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing twelfth in formational supplement[S].NCCLS documents,2002.M100-S12.
  • 5王涛,张克坚.对复方抗生素研发及评价的探讨[J].中国临床药理学杂志,2003,19(6):467-470. 被引量:8

二级参考文献12

共引文献12

同被引文献27

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部